Mark Guerin
Finanzdirektor/CFO bei TRAWS PHARMA, INC.
Vermögen: 48 083 $ am 30.04.2024
Aktive Positionen von Mark Guerin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TRAWS PHARMA, INC. | Finanzdirektor/CFO | 12.02.2016 | - |
| Comptroller/Controller/Auditor | 09.05.2014 | 12.02.2016 | |
| Geschäftsführer | 10.06.2022 | 01.04.2024 |
Karriereverlauf von Mark Guerin
Ehemalige bekannte Positionen von Mark Guerin
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
CardioKine, Inc.
 CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Finanzdirektor/CFO | 01.01.2009 | 01.12.2011 |
Barrier Therapeutics, Inc.
 Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Corporate Officer/Principal | - | - |
Ausbildung von Mark Guerin
| DeSales University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 1 |
| Chief Operating Officer | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TRAWS PHARMA, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
CardioKine, Inc.
CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Health Technology |
- Börse
- Insiders
- Mark Guerin
- Erfahrung
